Evidence map›Paper›PMID 40876740›Full record

ArticleChest2026

Artificial Intelligence-Based Echocardiography in Pulmonary Arterial Hypertension.

Bettia Celestin, Shadi P Bagherzadeh, Everton Santana, Matthew Frost, Mathias Iversen, Frida N Hermansson, Andrew Sweatt, Roham T Zamanian, Yoran M Hummel, Gabriela Gomez Rendon and 4 more

Abstract read
In one paragraph

Article in Chest, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Bettia CelestinDivision of Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Stanford Cardiovascular Institute, Palo Alto, CA.
Shadi P BagherzadehDivision of Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Stanford Cardiovascular Institute, Palo Alto, CA.
Everton SantanaDivision of Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Stanford Cardiovascular Institute, Palo Alto, CA.
Matthew FrostUs2.ai, Singapore, Singapore.
Mathias IversenUs2.ai, Singapore, Singapore.
Frida N HermanssonStanford Cardiovascular Institute, Palo Alto, CA.
Andrew SweattDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University, Palo Alto, CA.
Roham T ZamanianDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Stanford University, Palo Alto, CA.
Yoran M HummelUs2.ai, Singapore, Singapore.
Gabriela Gomez RendonJohnson & Johnson, Titusville, NJ.
Joseph YenJohnson & Johnson, Titusville, NJ.
Marinella SandrosJohnson & Johnson, Titusville, NJ.
Michael SalernoDivision of Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Stanford Cardiovascular Institute, Palo Alto, CA.
Francois HaddadDivision of Cardiovascular Medicine, Department of Medicine, Stanford University, Palo Alto, CA; Stanford Cardiovascular Institute, Palo Alto, CA. Electronic address: fhaddad@stanford.edu.

Funding

Reclassifying Pulmonary Arterial Hypertension Into Immune Phenotypes Using Machine LearningK23HL151892 · NHLBI · STANFORD UNIVERSITY · PI SWEATT, ANDREW JOHN · 2020 to 2024
$942k
NHLBI NIH HHS K23 HL151892
6 · The paper itself

Abstract

backgroundEchocardiography is central when assessing pulmonary hypertension (PH), but manual interpretation can be time-consuming and prone to error. RESEARCH QUESTION: Is a fully automated deep learning (DL) workflow in echocardiography reliable when assessing PH? STUDY DESIGN AND

methodsThis study had 2 parts: the first determined the bias and precision of DL reads by using Us2.ai software version 1.4.5 with core laboratory readers as the reference; the second part assessed the ability of DL to discriminate milder PH in patients referred for right heart catheterization (mean pulmonary artery pressure between 20 and 35 mm Hg). The first cohort (case-control) included 213 healthy individuals and 221 patients with pulmonary arterial hypertension. Parameters included peak tricuspid regurgitation velocity (TRV), right ventricular basal diameter, tricuspid annular plane systolic excursion, right atrial area, and right ventricular fractional area change (RVFAC). The referral cohort included 196 patients, with 171 patients having measurable peak TRV signals. Robust measures of bias and precision were reported, and area under the curve (AUC) analysis assessed discrimination.

resultsIn patients with pulmonary arterial hypertension, mean age was 48 years, 78% were female, and mean pulmonary artery pressure was 52 mm Hg. No significant bias was observed for peak TRV (0.90%; 95% CI, -0.17 to 1.57), right atrial area (1.71%; 95% CI, 0.59 to 3.34), and tricuspid annular plane systolic excursion (1.28%; 95% CI, -0.51 to 3.18), while RVFAC exhibited a significant bias of 11.46% (95% CI, 8.43 to 14.74). For all measurements except RVFAC, robust percentile precision remained below 15%. In the case-control cohort, peak TRV had AUCs of 0.99 and 0.98 for core laboratory and DL reads, respectively. The AUC for PH detection in the referral cohort was 0.79 for clinical laboratory reads and 0.75 for DL reads (P = .068).

interpretationA fully automated DL workflow for echocardiography in PH is promising and likely to improve efficiency in clinical practice.

Indexed as

Artificial IntelligenceDeep LearningEchocardiographyHypertension, PulmonaryPulmonary Arterial HypertensionAdultCase-Control StudiesFemaleHumansMaleMiddle Ageddeep learningechocardiographypulmonary hypertensionright heart

Identifiers

PMID40876740
PMCPMC13169424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.